Companies: 10,795·Total market cap: $144.5T
Ovation Science Inc.

Ovation Science Inc.

OVATFOTCHealthcare● Active
$0.04
+$0.00(+0.00%)
Market Cap$1345460
P/E Ratio
52W High$0.076
52W Low$0.0136

Ovation Science Inc. (OVATF) Revenue

Annual & quarterly revenue history · segment & region breakdown

OVATF · revenue · updated Jun 9, 2026

Core revenue metrics

Ovation Science Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
0 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Ovation Science Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
OVATF revenue by year · OVATF revenue history · OVATF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Ovation Science Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Ovation Science Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Ovation Science Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

OVATF revenue · 4 questions

OVATF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

OVATF revenueOVATF annual revenuewhat is OVATF revenueOVATF TTM revenue

Source: FMP · Ovation Science Inc. SEC filings · GAAP · Ovation Science Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026